Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 52,500 shares at $15.30 ($774K) on 2020-07-15, disclosed to the SEC on 2020-07-17.
Open-market sale of $774k CRNX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.30 | 17,500 | $268K | 34.6% |
| 2 | $14.46 | 17,500 | $253K | 32.7% |
| 3 | $14.46 | 17,500 | $253K | 32.7% |
| Total | $14.74 avg | 52,500 | $774K | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |